Efficacy and Safety of Re-Treatment with Bortezomib (Velcade (C)) in Patients with Multiple Myeloma: Results from a Prospective International Phase Ii Trial.
AuthID
P-003-TWF
P-003-TWF
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service